GlassScriptPhysician profile
Peter Henry Bast
NPI 1295937332
$1,306.86
in general payments reported to CMS, 2019-2025
18 companies · $170 in 2025
The $170 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $92.73 · 2020: $51.34 · 2021: $221 · 2022: $376 · 2023: $252 · 2024: $144 · 2025: $170.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $566.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $566.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $336.00 | 2021-2025 | Clareon, Rocklatan, Hydrus Microstent |
| Oyster Point Pharma, INC. | $123.53 | 2022-2025 | Tyrvaya, Ryzumvi, Ryzumvi |
| Kala Pharmaceuticals, INC. | $121.07 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $96.03 | 2020-2022 | |
| Aerie Pharmaceuticals, INC. | $88.25 | 2021 | |
| Tarsus Pharmaceuticals, INC. | $80.81 | 2024-2025 | Xdemvy |
| Biotissue Holdings INC. | $70.99 | 2021-2025 | |
| Bausch & Lomb Americas INC. | $51.94 | 2022-2023 | Vyzulta |
| Sun Pharmaceutical Industries INC. | $47.76 | 2021-2024 | Cequa |
| Horizon Therapeutics Plc | $44.85 | 2023 | Tepezza |
| Allergan, INC. | $43.71 | 2020-2022 | |
| Amgen INC. | $42.31 | 2024 | Tepezza |
| Thea Pharma INC. | $41.47 | 2023-2025 | Iyuzeh |
| Abbvie INC. | $39.64 | 2022-2023 | Alphagan P, Lumigan |
| Rxsight INC | $24.48 | 2023 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Handpiece, Rxsight Injector Cartridge |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dompe US, INC. | $22.59 | 2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $16.00 | 2019 | |
| Ocular Therapeutix, INC. | $15.43 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Bast listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.